Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Diseases (4)
- Alternative and Complementary Medicine (2)
- Disorders of Environmental Origin (2)
- Medical Specialties (2)
- Musculoskeletal Diseases (2)
-
- Pharmaceutics and Drug Design (2)
- Pharmacy and Pharmaceutical Sciences (2)
- Rheumatology (2)
- Skin and Connective Tissue Diseases (2)
- Amino Acids, Peptides, and Proteins (1)
- Biochemistry (1)
- Biochemistry, Biophysics, and Structural Biology (1)
- Biophysics (1)
- Chemistry (1)
- Life Sciences (1)
- Medicinal-Pharmaceutical Chemistry (1)
- Molecular Biology (1)
- Physical Chemistry (1)
- Physical Sciences and Mathematics (1)
- Keyword
-
- Anti-TNF (2)
- Toxic; plant extracts; trichomes; nettles; anti-inflammatory (2)
- Urtica dioica; urticaria; plants (2)
- Alzheimer’s disease (1)
- Binding interface (1)
-
- Biosimilar pharmaceuticals (1)
- Casenilin (1)
- Circular dichroism (1)
- Computational MD simulation (1)
- DMARDs (biologic) (1)
- DREAM (1)
- Drug discovery (1)
- Dynamics network analysis (1)
- Economic Evaluations (1)
- Fluorescence spectroscopy (1)
- Isothermal titration calorimetry (1)
- KChIP3 (1)
- Outcomes research (1)
- Pain modulation (1)
- Pharmacokinetics (1)
- Photothermal spectroscopy (1)
- Presenilin (1)
- Rheumatoid Arthritis (1)
- Treatment (1)
- Publication
- Publication Type
Articles 1 - 5 of 5
Full-Text Articles in Complex Mixtures
The Changing Landscape Of Biosimilars In Rheumatology, Thomas Dorner, Vibeke Strand, Paul Cornes, Joao Goncalves, Laszlo Gulacsi, Jonathan Kay, Tore K. Kvien, Josef S. Smolen, Yoshiya Tanaka, Gerd R. Burmester
The Changing Landscape Of Biosimilars In Rheumatology, Thomas Dorner, Vibeke Strand, Paul Cornes, Joao Goncalves, Laszlo Gulacsi, Jonathan Kay, Tore K. Kvien, Josef S. Smolen, Yoshiya Tanaka, Gerd R. Burmester
Jonathan Kay
Biosimilars remain a hot topic in rheumatology, and some physicians are cautious about their application in the real world. With many products coming to market and a wealth of guidelines and recommendations concerning their use, there is a need to understand the changing landscape and the real clinical and health-economic potential offered by these agents. Notably, rheumatologists will be at the forefront of the use of biosimilar monoclonal antibodies/soluble receptors. Biosimilars offer cost savings and health gains for our patients and will play an important role in treating rheumatic diseases. We hope that these lower costs will compensate for inequities …
Conformational Dynamics And Stability Associated With Magnesium Or Calcium Binding To Dream In The Regulation Of Interactions Between Dream And Dna Or Presenilins, Khoa Ngoc Pham
FIU Electronic Theses and Dissertations
Downstream regulatory element antagonist modulator (DREAM) is involved in various interactions with targets both inside and outside of the nucleus. In the cytoplasm, DREAM interacts with the C-terminal fragments of presenilins to facilitate the production of β-amyloid plaques in Alzheimer’s disease. In the nucleus, Ca2+ free DREAM directly binds to specific downstream regulatory elements of prodynorphin/c-fos gene to repress the gene transcription in pain modulation. These interactions are regulated by Ca2+ and/or Mg2+ association at the EF-hands in DREAM. Therefore, understanding the conformational dynamics and stability associated with Ca2+ and/or Mg2+ binding to DREAM …
Biosimilars In Rheumatology: What The Clinician Should Know, Gilberto Castaneda-Hernandez, Rodrigo Gonzalez-Ramirez, Jonathan Kay, Morton A. Scheinberg
Biosimilars In Rheumatology: What The Clinician Should Know, Gilberto Castaneda-Hernandez, Rodrigo Gonzalez-Ramirez, Jonathan Kay, Morton A. Scheinberg
Jonathan Kay
Biosimilars are now a reality in rheumatology. Although analytical and non-clinical procedures to establish similarity have evolved significantly, clinical trials demonstrating equivalent efficacy and safety are absolutely required for all biosimilars. The design of such trials, including equivalence and non-inferiority statistical approaches, are discussed. Clinical evidence on biosimilars that have been approved recently or are presently being developed for use in rheumatology is also reviewed and contrasted with that available for biomimics (or intended copies), which are non-innovator biologics that are marketed in several countries but have not undergone review according to a regulatory pathway for biosimilars.
Stinging Nettle: The Bad, The Good, The Unknown, Dennis J. Baumgardner
Stinging Nettle: The Bad, The Good, The Unknown, Dennis J. Baumgardner
Dennis J. Baumgardner, MD
Stinging nettle (Urtica dioica) is native to most of the United States. It has a characteristic description and distribution in the environment. Physical contact with numerous tiny needlelike hairs present on leaves and stems of this plant may result in a contact urticarial dermatitis due to chemical and mechanical irritation triggered by skin penetration of the hairs. The manifestations are self-limited in humans and may be treated by washing the skin, topical preparations and oral antihistamines. Explanation of the natural history of these encounters to the patient is helpful in reducing the sometimes significant anxiety. Preparations and extracts of stinging …
Stinging Nettle: The Bad, The Good, The Unknown, Dennis J. Baumgardner
Stinging Nettle: The Bad, The Good, The Unknown, Dennis J. Baumgardner
Journal of Patient-Centered Research and Reviews
Stinging nettle (Urtica dioica) is native to most of the United States. It has a characteristic description and distribution in the environment. Physical contact with numerous tiny needlelike hairs present on leaves and stems of this plant may result in a contact urticarial dermatitis due to chemical and mechanical irritation triggered by skin penetration of the hairs. The manifestations are self-limited in humans and may be treated by washing the skin, topical preparations and oral antihistamines. Explanation of the natural history of these encounters to the patient is helpful in reducing the sometimes significant anxiety. Preparations and extracts …